Muscle News and Research

RSS

Support from supervisors can help employees recover from somatic symptoms

A worker experiencing the stress of intense workdays might develop somatic symptoms, such as stomach ache or headache, which will eventually lead to taking leave of absence.

6 Feb 2012

Neutra to initiate clinical trials of new all-natural weight-loss supplement

Neutra Corp., an emerging nutraceuticals provider, expects to begin clinical trials of its eagerly anticipated new all-natural weight-loss supplement as early as this week when the company's first batch of Pure Plus arrives from the manufacturer.

6 Feb 2012

Scientists identify genetic variant that increases risk of ischemic stroke

A genetic variant that increases the risk of a common type of stroke has been identified by scientists in a study published online in Nature Genetics today. This is one of the few genetic variants to date to be associated with risk of stroke and the discovery opens up new possibilities for treatment.

6 Feb 2012

Merck Serono enters development agreement with Threshold for hypoxia-targeted drug

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.

3 Feb 2012

New procedure rapidly induces nerve regeneration

American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research.

3 Feb 2012

Chronic hyperglycemia may lead to cardiac damage

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that hyperglycemia (high blood sugar) injures the heart, even in patients without a history of heart disease or diabetes.

3 Feb 2012

Skin cells converted to brain cells without intermediate stem cell stage

Researchers from California have successfully converted mouse skin cells into cells which develop into the main components of the brain. The experiment, reported in Proceedings of the National Academy of Sciences, is notable because it skipped the middle “stem cell” stage in the process.

2 Feb 2012

The Methodist Hospital now offers advanced rehabilitation system for treatment of foot drop

The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.

2 Feb 2012

Healthy lung tissue transplantation shows promise for patients with pulmonary diseases

For patients suffering from severe pulmonary diseases including emphysema, lung cancer or fibrosis, transplantation of healthy lung tissue may offer the best chance for survival. The surgical procedure, however, faces two primary challenges: an acute shortage of donor lungs and rejection of transplanted tissue by the recipient's immune system.

2 Feb 2012

Ligand announces results from melphalan Phase II study on multiple myeloma

Ligand Pharmaceuticals Incorporated announced that results from the Phase II study of its Captisol-enabled, propylene glycol-free (PG-free) Melphalan program were featured this evening in a poster presentation at the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society for Blood and Marrow Transplantation (ASBMT) in San Diego.

2 Feb 2012

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.

1 Feb 2012

Brief 10-minute massage helps reduce inflammation in muscle

Researchers at McMaster University have discovered a brief 10-minute massage helps reduce inflammation in muscle.

1 Feb 2012

New York hospital offers at-home method for tissue expansion for breast reconstruction surgery

NewYork-Presbyterian Hospital/Columbia University Medical Center is the first hospital in the New York metro area to offer breast cancer survivors an at-home method for tissue expansion in preparation for breast reconstruction surgery. Patients use a remote control to gradually create a space within their chest wall for a breast implant.

1 Feb 2012

RMC first in N.J. to offer TESSYS minimally invasive surgery for patients with herniated discs

Riverview Medical Center, part of Meridian Neuroscience, today announced it is the only hospital in the state of New Jersey to offer patients the TESSYS surgery method, a minimally invasive procedure for the treatment of herniated discs.

1 Feb 2012

Potential way to block second wave of death from pneumonia treatment

An international research team may have found a way to block a second wave of death that can result from pneumonia treatment.

1 Feb 2012

Novartis' Gleevec receives FDA approval for use in patients with CD117-positive GIST

The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors.

1 Feb 2012

Fluorescence microscopy reveals 3-D picture of myoV's transport capacity

A new study in the Journal of General Physiology uses state-of-the-art fluorescence microscopy to provide a striking 3-D picture of how class V myosins (myoV) "walk" along their actin track.

1 Feb 2012

Breast cancer survivors use at-home method to prep their breasts for reconstruction

31 Jan 2012

Roche’s skin cancer drug Erivedge gets FDA nod

The Food and Drugs Administration (FDA) this Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.

31 Jan 2012

Dairy products help weight loss: Study

For these findings the researchers reviewed 14 clinical trials involving 883 adults. The trials looked at how eating dairy food impacted on people's weight, body fat, waistlines and lean muscle mass. In the study published in the International Journal of Obesity, the authors said they wanted to reveal more about the relationship between weight loss and dairy consumption.

31 Jan 2012

Muscle News and Research

Support from supervisors can help employees recover from somatic symptoms

Neutra to initiate clinical trials of new all-natural weight-loss supplement

Scientists identify genetic variant that increases risk of ischemic stroke

Merck Serono enters development agreement with Threshold for hypoxia-targeted drug

New procedure rapidly induces nerve regeneration

Chronic hyperglycemia may lead to cardiac damage

Skin cells converted to brain cells without intermediate stem cell stage

The Methodist Hospital now offers advanced rehabilitation system for treatment of foot drop

Healthy lung tissue transplantation shows promise for patients with pulmonary diseases

Ligand announces results from melphalan Phase II study on multiple myeloma

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

Brief 10-minute massage helps reduce inflammation in muscle

New York hospital offers at-home method for tissue expansion for breast reconstruction surgery

RMC first in N.J. to offer TESSYS minimally invasive surgery for patients with herniated discs

Potential way to block second wave of death from pneumonia treatment

Novartis' Gleevec receives FDA approval for use in patients with CD117-positive GIST

Fluorescence microscopy reveals 3-D picture of myoV's transport capacity

Breast cancer survivors use at-home method to prep their breasts for reconstruction

Roche’s skin cancer drug Erivedge gets FDA nod

Dairy products help weight loss: Study

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News